Target Serum Urate

Do Gout Patients Know Their Goal?

Brian W. Coburn, Kayli A. Bendlin, Harlan Sayles, Kathryn S. Hentzen, Michaela M. Hrdy, Ted R Mikuls

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: To examine gout patients’ knowledge of their condition, including the central role of achieving and maintaining the serum urate (SU) goal with the use of urate-lowering therapy (ULT). Methods: This study of 612 gout patients was conducted at a Veterans Affairs medical center. Gout patients were included based on administrative diagnostic codes and receipt of at least 1 allopurinol prescription over a 1-year period. Questionnaires were mailed to patients and linked to medical records data. The questionnaire included gout-specific knowledge questions, the Patient Activation Measure, and self-reported health outcomes. Knowledge was assessed descriptively. Multivariable logistic regression was used to determine predictors of SU goal knowledge. Associations of knowledge with health outcomes were examined in exploratory analyses. Results: The questionnaire had a 62% response rate. Only 14% of patients knew their SU goal, while the majority answered correctly for the other 5 gout-specific knowledge questions. In adjusted analyses, having a rheumatologist as initial prescriber (odds ratio [OR] 3.0 [95% confidence interval (95% CI) 1.4–6.2]) and knowing all of the other 5 gout-specific knowledge questions (OR 2.1 [95% CI 1.3–3.4]) were associated with greater odds of knowing the SU goal. SU goal knowledge was associated with self-reported global health status, but not with self-reported health-related quality of life or gout-specific health status. Conclusion: There is a knowledge deficit regarding the SU treatment goal among gout patients receiving ULT, despite generally high levels of other gout-specific knowledge. SU goal information may be an important and underutilized concept among providers treating gout patients.

Original languageEnglish (US)
Pages (from-to)1028-1035
Number of pages8
JournalArthritis Care and Research
Volume68
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Gout
Uric Acid
Serum
Health Status
Odds Ratio
Confidence Intervals
Patient Participation
Allopurinol
Health
Veterans
Medical Records
Prescriptions
Therapeutics
Logistic Models
Quality of Life

ASJC Scopus subject areas

  • Rheumatology

Cite this

Coburn, B. W., Bendlin, K. A., Sayles, H., Hentzen, K. S., Hrdy, M. M., & Mikuls, T. R. (2016). Target Serum Urate: Do Gout Patients Know Their Goal? Arthritis Care and Research, 68(7), 1028-1035. https://doi.org/10.1002/acr.22785

Target Serum Urate : Do Gout Patients Know Their Goal? / Coburn, Brian W.; Bendlin, Kayli A.; Sayles, Harlan; Hentzen, Kathryn S.; Hrdy, Michaela M.; Mikuls, Ted R.

In: Arthritis Care and Research, Vol. 68, No. 7, 01.07.2016, p. 1028-1035.

Research output: Contribution to journalArticle

Coburn, BW, Bendlin, KA, Sayles, H, Hentzen, KS, Hrdy, MM & Mikuls, TR 2016, 'Target Serum Urate: Do Gout Patients Know Their Goal?', Arthritis Care and Research, vol. 68, no. 7, pp. 1028-1035. https://doi.org/10.1002/acr.22785
Coburn BW, Bendlin KA, Sayles H, Hentzen KS, Hrdy MM, Mikuls TR. Target Serum Urate: Do Gout Patients Know Their Goal? Arthritis Care and Research. 2016 Jul 1;68(7):1028-1035. https://doi.org/10.1002/acr.22785
Coburn, Brian W. ; Bendlin, Kayli A. ; Sayles, Harlan ; Hentzen, Kathryn S. ; Hrdy, Michaela M. ; Mikuls, Ted R. / Target Serum Urate : Do Gout Patients Know Their Goal?. In: Arthritis Care and Research. 2016 ; Vol. 68, No. 7. pp. 1028-1035.
@article{6676e80f80ce4e25a79003849675ffa5,
title = "Target Serum Urate: Do Gout Patients Know Their Goal?",
abstract = "Objective: To examine gout patients’ knowledge of their condition, including the central role of achieving and maintaining the serum urate (SU) goal with the use of urate-lowering therapy (ULT). Methods: This study of 612 gout patients was conducted at a Veterans Affairs medical center. Gout patients were included based on administrative diagnostic codes and receipt of at least 1 allopurinol prescription over a 1-year period. Questionnaires were mailed to patients and linked to medical records data. The questionnaire included gout-specific knowledge questions, the Patient Activation Measure, and self-reported health outcomes. Knowledge was assessed descriptively. Multivariable logistic regression was used to determine predictors of SU goal knowledge. Associations of knowledge with health outcomes were examined in exploratory analyses. Results: The questionnaire had a 62{\%} response rate. Only 14{\%} of patients knew their SU goal, while the majority answered correctly for the other 5 gout-specific knowledge questions. In adjusted analyses, having a rheumatologist as initial prescriber (odds ratio [OR] 3.0 [95{\%} confidence interval (95{\%} CI) 1.4–6.2]) and knowing all of the other 5 gout-specific knowledge questions (OR 2.1 [95{\%} CI 1.3–3.4]) were associated with greater odds of knowing the SU goal. SU goal knowledge was associated with self-reported global health status, but not with self-reported health-related quality of life or gout-specific health status. Conclusion: There is a knowledge deficit regarding the SU treatment goal among gout patients receiving ULT, despite generally high levels of other gout-specific knowledge. SU goal information may be an important and underutilized concept among providers treating gout patients.",
author = "Coburn, {Brian W.} and Bendlin, {Kayli A.} and Harlan Sayles and Hentzen, {Kathryn S.} and Hrdy, {Michaela M.} and Mikuls, {Ted R}",
year = "2016",
month = "7",
day = "1",
doi = "10.1002/acr.22785",
language = "English (US)",
volume = "68",
pages = "1028--1035",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Target Serum Urate

T2 - Do Gout Patients Know Their Goal?

AU - Coburn, Brian W.

AU - Bendlin, Kayli A.

AU - Sayles, Harlan

AU - Hentzen, Kathryn S.

AU - Hrdy, Michaela M.

AU - Mikuls, Ted R

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Objective: To examine gout patients’ knowledge of their condition, including the central role of achieving and maintaining the serum urate (SU) goal with the use of urate-lowering therapy (ULT). Methods: This study of 612 gout patients was conducted at a Veterans Affairs medical center. Gout patients were included based on administrative diagnostic codes and receipt of at least 1 allopurinol prescription over a 1-year period. Questionnaires were mailed to patients and linked to medical records data. The questionnaire included gout-specific knowledge questions, the Patient Activation Measure, and self-reported health outcomes. Knowledge was assessed descriptively. Multivariable logistic regression was used to determine predictors of SU goal knowledge. Associations of knowledge with health outcomes were examined in exploratory analyses. Results: The questionnaire had a 62% response rate. Only 14% of patients knew their SU goal, while the majority answered correctly for the other 5 gout-specific knowledge questions. In adjusted analyses, having a rheumatologist as initial prescriber (odds ratio [OR] 3.0 [95% confidence interval (95% CI) 1.4–6.2]) and knowing all of the other 5 gout-specific knowledge questions (OR 2.1 [95% CI 1.3–3.4]) were associated with greater odds of knowing the SU goal. SU goal knowledge was associated with self-reported global health status, but not with self-reported health-related quality of life or gout-specific health status. Conclusion: There is a knowledge deficit regarding the SU treatment goal among gout patients receiving ULT, despite generally high levels of other gout-specific knowledge. SU goal information may be an important and underutilized concept among providers treating gout patients.

AB - Objective: To examine gout patients’ knowledge of their condition, including the central role of achieving and maintaining the serum urate (SU) goal with the use of urate-lowering therapy (ULT). Methods: This study of 612 gout patients was conducted at a Veterans Affairs medical center. Gout patients were included based on administrative diagnostic codes and receipt of at least 1 allopurinol prescription over a 1-year period. Questionnaires were mailed to patients and linked to medical records data. The questionnaire included gout-specific knowledge questions, the Patient Activation Measure, and self-reported health outcomes. Knowledge was assessed descriptively. Multivariable logistic regression was used to determine predictors of SU goal knowledge. Associations of knowledge with health outcomes were examined in exploratory analyses. Results: The questionnaire had a 62% response rate. Only 14% of patients knew their SU goal, while the majority answered correctly for the other 5 gout-specific knowledge questions. In adjusted analyses, having a rheumatologist as initial prescriber (odds ratio [OR] 3.0 [95% confidence interval (95% CI) 1.4–6.2]) and knowing all of the other 5 gout-specific knowledge questions (OR 2.1 [95% CI 1.3–3.4]) were associated with greater odds of knowing the SU goal. SU goal knowledge was associated with self-reported global health status, but not with self-reported health-related quality of life or gout-specific health status. Conclusion: There is a knowledge deficit regarding the SU treatment goal among gout patients receiving ULT, despite generally high levels of other gout-specific knowledge. SU goal information may be an important and underutilized concept among providers treating gout patients.

UR - http://www.scopus.com/inward/record.url?scp=84976596284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976596284&partnerID=8YFLogxK

U2 - 10.1002/acr.22785

DO - 10.1002/acr.22785

M3 - Article

VL - 68

SP - 1028

EP - 1035

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -